| 000 | 01749 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513075500.0 | ||
| 264 | 0 | _c19931112 | |
| 008 | 199311s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jcem.77.4.8408471 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMulligan, K | |
| 245 | 0 | 0 |
_aAnabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cOct 1993 |
||
| 300 |
_a956-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aEmaciation _xdrug therapy |
| 650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
| 650 | 0 | 4 |
_aGrowth Hormone _xpharmacology |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitrogen _xurine |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPotassium _xblood |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aSodium _xblood |
| 650 | 0 | 4 |
_aUrea _xurine |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aGrunfeld, C | |
| 700 | 1 | _aHellerstein, M K | |
| 700 | 1 | _aNeese, R A | |
| 700 | 1 | _aSchambelan, M | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 77 _gno. 4 _gp. 956-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jcem.77.4.8408471 _zAvailable from publisher's website |
| 999 |
_c8407745 _d8407745 |
||